Inderal (Propranolol Hydrochloride)

Propranolol blocks both β1 and β2 adrenergic receptors, preventing adrenaline and noradrenaline from activating these pathways. This reduces heart rate, contractility, and renin release, leading to lower blood pressure and decreased cardiac workload, while also stabilising vascular tone that contributes to migraine and tremor control.

The dosage of Inderal is individualized by the prescribing clinician based on the patient’s condition, age, weight, renal and hepatic function, and response to therapy. Only a qualified healthcare professional should determine the appropriate dose and schedule.

Safety of propranolol in pregnancy or while nursing has not been definitively established. Physicians weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and monitoring strategies with their healthcare provider.

To request Inderal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Inderal (propranolol) is a non‑selective beta blocker, affecting both β1 and β2 receptors, whereas some alternatives such as atenolol or metoprolol are β1‑selective. Non‑selectivity offers broader therapeutic effects for migraine and tremor but may increase the risk of bronchospasm in patients with reactive airway disease.

Inderal should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight, and excessive heat to maintain its stability and potency throughout its shelf life.

Inderal is taken orally, usually as a tablet, with or without food as directed by the prescriber. The exact timing (e.g., once daily or divided doses) is determined by the treating physician based on the therapeutic goal and patient tolerance.

Serious risks include severe bradycardia, profound hypotension, bronchospasm in patients with asthma or COPD, heart block, and rare allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience fainting, difficulty breathing, or rapid swelling.

Inderal is contraindicated in individuals with known hypersensitivity to propranolol, uncontrolled asthma, severe chronic obstructive pulmonary disease, certain types of heart block, or profound bradycardia. It should also be used with caution in patients with diabetes, peripheral vascular disease, or severe liver impairment.